전체 프로그램

ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved15 programs
AntibodyLimited DatastalePENG YUANPhase 2

QL1706 (Iparomlimab and Tuvonralimab, Iparomlimab and Tuvonralimab (QL1706))

Platinum Resistant Ovarian Cancer; Platinum Refractory Epithelial Ovarian Cancer · Gastric Cancer (GC)

#GastricCancerGC#Antibody#Phase2#Popular#monoclonal-antibody+4
Trials 143Status Recruiting
CGTStandard DatabasestaleIovance Biotherapeutics, Inc.Phase 2

TCR (E7 T Cell Receptor, E7 T Cell Receptor (TCR))

Uterine Cervical Neoplasms · Squamous Lntraepithelial Lesions of Vulv

#SquamousLntraepithelialLesionsof#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 124Status Discontinued
CGTStandard DatabasestaleMedigene AGPhase 2

Lymphodepletion (Lymphodepletion)

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 60Status Discontinued
CGTLimited DatastaleMedigene AGPhase 1

MDG1015 (TCR-T cells, TCR-T cells (MDG1015))

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 60Status Recruiting
CGTStandard DatabasestaleCelldex TherapeuticsPhase 2

TCR-transduced T cells (TCR-transduced T cells)

Stage IV Skin Melanoma; Eye; Melanoma · Malignant Epithelial Neoplasms

#MalignantEpithelialNeoplasms#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 51Status Recruiting
CGTStandard DatabasestaleTScan Therapeutics, Inc.Phase 2

E7 TCR (E7 TCR)

Papillomavirus Infections; Oropharyngeal Neoplasms · Cervical Intraepithelial Neoplasia

#CervicalIntraepithelialNeoplasia#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 11Status Discontinued
CGTLimited DatastaleBeijing BiotechPhase 2

Dual-target CAR-NK cell product (Dual-target CAR-NK cell product)

Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 10Status Recruiting
AntibodyCurated CorestaleSutro Biopharma, Inc.Phase 3

Luveltamab tazevibulin (Luveltamab tazevibulin)

Ovarian Cancer; Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase3#BioJungboMoa-pick#monoclonal-antibody+2
Trials 3Status Discontinued
CGTLimited DatastaleGuangdong ProCapZoom Bioscience…Phase 1

SZ011 CAR-NK (SZ011 CAR-NK)

Ovarian Epithelial Carcinoma · Advanced Triple Negative Breast Cancer

#AdvancedTripleNegativeBreastCanc#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

CAR.B7-H3 (CAR.B7-H3)

Epithelial Ovarian Cancer · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

CART-meso (CART-meso)

Metastatic Pancreatic (Ductal) Adenocarcinoma; Epithelial Ovarian Cancer · Metastatic Pancreatic (Ductal) Adenocarc

#MetastaticPancreaticDuctalAdenoc#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 2

E7 TCR cells (E7 TCR cells)

Papillomavirus Infections; Cervical Intraepithelial Neoplasia · Papillomavirus Infections

#PapillomavirusInfections#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleShanghai East HospitalPhase 1

LCAR-M23 cells (LCAR-M23 cells)

Epithelial Ovarian Cancer · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Discontinued
AntibodyLimited DatastaleNational Cancer Centre, Singapo…Phase 2

Oregovomab (Oregovomab)

Epithelial Ovarian Cancer · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#Antibody#Phase2#monoclonal-antibody#National
Trials 1Status Active
CGTLimited DatastaleIntima Bioscience, Inc.Phase 2

TIL (Tumor-Infiltrating Lymphocytes, Tumor-Infiltrating Lymphocytes (TIL))

Gastrointestinal Epithelial Cancer; Gastrointestinal Neoplasms · Gastrointestinal Epithelial Cancer

#GastrointestinalEpithelialCancer#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active